Compare Cytokinetics Inc (CYTK) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs BIO-TECHNE Corp — how do they compare? Cytokinetics Inc trades at $82.05 (market cap $11.16B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: Cytokinetics Inc and BIO-TECHNE Corp are close in size by market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | TECH | |
|---|---|---|
Market Cap | $11.16B | $11.12B |
Sector | Technology | Health |
52-Week High | $87.26 | $71.38 |
52-Week Low | $33.23 | $43.31 |
Enterprise Value | $11.63B | $11.20B |
Dividend Yield | — | 0.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
